nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextrothyroxine—Choking—Progesterone—uterine cancer	0.0402	0.0774	CcSEcCtD
Dextrothyroxine—Infertility—Progesterone—uterine cancer	0.0282	0.0542	CcSEcCtD
Dextrothyroxine—Benign intracranial hypertension—Medroxyprogesterone Acetate—uterine cancer	0.0227	0.0436	CcSEcCtD
Dextrothyroxine—Hyperthyroidism—Medroxyprogesterone Acetate—uterine cancer	0.0169	0.0324	CcSEcCtD
Dextrothyroxine—Menstruation irregular—Progesterone—uterine cancer	0.0133	0.0255	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—CDKN1C—uterine cancer	0.0124	0.0717	CbGpPWpGaD
Dextrothyroxine—SLC7A5—myometrium—uterine cancer	0.0124	0.0402	CbGeAlD
Dextrothyroxine—SLCO4C1—renal system—uterine cancer	0.0123	0.04	CbGeAlD
Dextrothyroxine—Menstruation irregular—Medroxyprogesterone Acetate—uterine cancer	0.012	0.0231	CcSEcCtD
Dextrothyroxine—SLCO4C1—endometrium—uterine cancer	0.0119	0.0386	CbGeAlD
Dextrothyroxine—THRB—renal system—uterine cancer	0.0118	0.0383	CbGeAlD
Dextrothyroxine—THRA—renal system—uterine cancer	0.0118	0.0383	CbGeAlD
Dextrothyroxine—TPO—Hematopoietic Stem Cell Differentiation—CSF3—uterine cancer	0.0116	0.067	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—mammalian vulva—uterine cancer	0.0115	0.0374	CbGeAlD
Dextrothyroxine—SLCO4A1—myometrium—uterine cancer	0.0108	0.0351	CbGeAlD
Dextrothyroxine—SLCO1C1—renal system—uterine cancer	0.0098	0.0319	CbGeAlD
Dextrothyroxine—SLC7A5—epithelium—uterine cancer	0.00969	0.0315	CbGeAlD
Dextrothyroxine—SLC7A5—uterine cervix—uterine cancer	0.00961	0.0313	CbGeAlD
Dextrothyroxine—THRA—female reproductive system—uterine cancer	0.00944	0.0307	CbGeAlD
Dextrothyroxine—THRB—female reproductive system—uterine cancer	0.00944	0.0307	CbGeAlD
Dextrothyroxine—TPO—Differentiation Pathway—INHBA—uterine cancer	0.00943	0.0547	CbGpPWpGaD
Dextrothyroxine—SLC7A5—smooth muscle tissue—uterine cancer	0.00934	0.0304	CbGeAlD
Dextrothyroxine—SLC7A5—decidua—uterine cancer	0.00916	0.0298	CbGeAlD
Dextrothyroxine—SLCO4C1—vagina—uterine cancer	0.0089	0.029	CbGeAlD
Dextrothyroxine—SLC7A5—endometrium—uterine cancer	0.00869	0.0283	CbGeAlD
Dextrothyroxine—THRB—female gonad—uterine cancer	0.00859	0.0279	CbGeAlD
Dextrothyroxine—THRA—female gonad—uterine cancer	0.00859	0.0279	CbGeAlD
Dextrothyroxine—THRB—vagina—uterine cancer	0.00854	0.0278	CbGeAlD
Dextrothyroxine—SLC7A5—mammalian vulva—uterine cancer	0.00841	0.0273	CbGeAlD
Dextrothyroxine—SLC7A5—uterus—uterine cancer	0.00801	0.026	CbGeAlD
Dextrothyroxine—SLCO4A1—decidua—uterine cancer	0.008	0.026	CbGeAlD
Dextrothyroxine—SLCO4A1—renal system—uterine cancer	0.00785	0.0255	CbGeAlD
Dextrothyroxine—SLCO4A1—endometrium—uterine cancer	0.00759	0.0247	CbGeAlD
Dextrothyroxine—THRA—Nuclear Receptors—PGR—uterine cancer	0.00747	0.0433	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptors—PGR—uterine cancer	0.00747	0.0433	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—mammalian vulva—uterine cancer	0.00734	0.0239	CbGeAlD
Dextrothyroxine—SLC7A5—female reproductive system—uterine cancer	0.0072	0.0234	CbGeAlD
Dextrothyroxine—SLCO1B1—renal system—uterine cancer	0.00691	0.0225	CbGeAlD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—NFE2L2—uterine cancer	0.00669	0.0388	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—ESR2—uterine cancer	0.00658	0.0381	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptors—ESR2—uterine cancer	0.00658	0.0381	CbGpPWpGaD
Dextrothyroxine—SLC7A5—female gonad—uterine cancer	0.00655	0.0213	CbGeAlD
Dextrothyroxine—SLC7A5—vagina—uterine cancer	0.00651	0.0212	CbGeAlD
Dextrothyroxine—SLCO4A1—female reproductive system—uterine cancer	0.00629	0.0204	CbGeAlD
Dextrothyroxine—Disorientation—Progesterone—uterine cancer	0.00596	0.0115	CcSEcCtD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.00591	0.0342	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—PGR—uterine cancer	0.00591	0.0342	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—vagina—uterine cancer	0.00569	0.0185	CbGeAlD
Dextrothyroxine—Increased appetite—Progesterone—uterine cancer	0.00568	0.0109	CcSEcCtD
Dextrothyroxine—SLCO1B1—female reproductive system—uterine cancer	0.00553	0.018	CbGeAlD
Dextrothyroxine—THRA—lymph node—uterine cancer	0.00552	0.018	CbGeAlD
Dextrothyroxine—THRB—lymph node—uterine cancer	0.00552	0.018	CbGeAlD
Dextrothyroxine—Cardiac failure congestive—Medroxyprogesterone Acetate—uterine cancer	0.00533	0.0103	CcSEcCtD
Dextrothyroxine—Affect lability—Progesterone—uterine cancer	0.00525	0.0101	CcSEcCtD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.0052	0.0301	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—ESR2—uterine cancer	0.0052	0.0301	CbGpPWpGaD
Dextrothyroxine—Increased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00515	0.0099	CcSEcCtD
Dextrothyroxine—Irritability—Progesterone—uterine cancer	0.00509	0.0098	CcSEcCtD
Dextrothyroxine—Mood swings—Progesterone—uterine cancer	0.00505	0.00972	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Medroxyprogesterone Acetate—uterine cancer	0.00495	0.00953	CcSEcCtD
Dextrothyroxine—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.00476	0.00915	CcSEcCtD
Dextrothyroxine—Irritability—Medroxyprogesterone Acetate—uterine cancer	0.00462	0.00888	CcSEcCtD
Dextrothyroxine—Dysphagia—Progesterone—uterine cancer	0.00461	0.00887	CcSEcCtD
Dextrothyroxine—SLCO1C1—lymph node—uterine cancer	0.00459	0.0149	CbGeAlD
Dextrothyroxine—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.00458	0.00881	CcSEcCtD
Dextrothyroxine—Angina pectoris—Progesterone—uterine cancer	0.00449	0.00864	CcSEcCtD
Dextrothyroxine—Sweating increased—Progesterone—uterine cancer	0.00449	0.00864	CcSEcCtD
Dextrothyroxine—Muscular weakness—Medroxyprogesterone Acetate—uterine cancer	0.00426	0.0082	CcSEcCtD
Dextrothyroxine—SLC7A5—lymph node—uterine cancer	0.00421	0.0137	CbGeAlD
Dextrothyroxine—Dysphagia—Medroxyprogesterone Acetate—uterine cancer	0.00418	0.00804	CcSEcCtD
Dextrothyroxine—Weight decreased—Progesterone—uterine cancer	0.00417	0.00802	CcSEcCtD
Dextrothyroxine—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.00407	0.00783	CcSEcCtD
Dextrothyroxine—THRB—Nuclear Receptors—ESR1—uterine cancer	0.00399	0.0231	CbGpPWpGaD
Dextrothyroxine—THRA—Nuclear Receptors—ESR1—uterine cancer	0.00399	0.0231	CbGpPWpGaD
Dextrothyroxine—Body temperature increased—Carboplatin—uterine cancer	0.00395	0.00759	CcSEcCtD
Dextrothyroxine—Weight decreased—Medroxyprogesterone Acetate—uterine cancer	0.00378	0.00727	CcSEcCtD
Dextrothyroxine—SLCO4A1—lymph node—uterine cancer	0.00368	0.012	CbGeAlD
Dextrothyroxine—Acute coronary syndrome—Medroxyprogesterone Acetate—uterine cancer	0.00367	0.00706	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Medroxyprogesterone Acetate—uterine cancer	0.00365	0.00702	CcSEcCtD
Dextrothyroxine—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.00357	0.00687	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—IGF1R—uterine cancer	0.00343	0.0199	CbGpPWpGaD
Dextrothyroxine—Alopecia—Progesterone—uterine cancer	0.00326	0.00627	CcSEcCtD
Dextrothyroxine—Dysphagia—Dactinomycin—uterine cancer	0.00326	0.00627	CcSEcCtD
Dextrothyroxine—Tension—Progesterone—uterine cancer	0.00315	0.00606	CcSEcCtD
Dextrothyroxine—THRA—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00315	0.0183	CbGpPWpGaD
Dextrothyroxine—THRB—Nuclear Receptor transcription pathway—ESR1—uterine cancer	0.00315	0.0183	CbGpPWpGaD
Dextrothyroxine—Nervousness—Progesterone—uterine cancer	0.00312	0.006	CcSEcCtD
Dextrothyroxine—SLCO1B1—Bile acid and bile salt metabolism—AKR1C1—uterine cancer	0.00308	0.0179	CbGpPWpGaD
Dextrothyroxine—Tremor—Progesterone—uterine cancer	0.00301	0.00579	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Etoposide—uterine cancer	0.00301	0.00579	CcSEcCtD
Dextrothyroxine—Alopecia—Medroxyprogesterone Acetate—uterine cancer	0.00296	0.00569	CcSEcCtD
Dextrothyroxine—Angioedema—Progesterone—uterine cancer	0.00294	0.00565	CcSEcCtD
Dextrothyroxine—Tension—Medroxyprogesterone Acetate—uterine cancer	0.00286	0.0055	CcSEcCtD
Dextrothyroxine—Palpitations—Progesterone—uterine cancer	0.00284	0.00546	CcSEcCtD
Dextrothyroxine—Nervousness—Medroxyprogesterone Acetate—uterine cancer	0.00283	0.00544	CcSEcCtD
Dextrothyroxine—Cardiac failure—Etoposide—uterine cancer	0.0028	0.00538	CcSEcCtD
Dextrothyroxine—Convulsion—Progesterone—uterine cancer	0.00278	0.00535	CcSEcCtD
Dextrothyroxine—Arthralgia—Progesterone—uterine cancer	0.00274	0.00526	CcSEcCtD
Dextrothyroxine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00273	0.00525	CcSEcCtD
Dextrothyroxine—Anxiety—Progesterone—uterine cancer	0.00273	0.00524	CcSEcCtD
Dextrothyroxine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.00268	0.00515	CcSEcCtD
Dextrothyroxine—Angioedema—Medroxyprogesterone Acetate—uterine cancer	0.00266	0.00512	CcSEcCtD
Dextrothyroxine—Confusional state—Progesterone—uterine cancer	0.00264	0.00509	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Etoposide—uterine cancer	0.0026	0.00499	CcSEcCtD
Dextrothyroxine—Shock—Progesterone—uterine cancer	0.00258	0.00496	CcSEcCtD
Dextrothyroxine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.00257	0.00495	CcSEcCtD
Dextrothyroxine—Tachycardia—Progesterone—uterine cancer	0.00256	0.00492	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Progesterone—uterine cancer	0.00254	0.00488	CcSEcCtD
Dextrothyroxine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.00252	0.00485	CcSEcCtD
Dextrothyroxine—Arthralgia—Medroxyprogesterone Acetate—uterine cancer	0.00248	0.00477	CcSEcCtD
Dextrothyroxine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00247	0.00475	CcSEcCtD
Dextrothyroxine—Flushing—Dactinomycin—uterine cancer	0.00242	0.00466	CcSEcCtD
Dextrothyroxine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.0024	0.00461	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00239	0.0046	CcSEcCtD
Dextrothyroxine—SLCO1B1—Bile acid and bile salt metabolism—AKR1C3—uterine cancer	0.00237	0.0138	CbGpPWpGaD
Dextrothyroxine—Insomnia—Progesterone—uterine cancer	0.00237	0.00456	CcSEcCtD
Dextrothyroxine—Dysphagia—Etoposide—uterine cancer	0.00236	0.00454	CcSEcCtD
Dextrothyroxine—Dyspnoea—Progesterone—uterine cancer	0.00234	0.0045	CcSEcCtD
Dextrothyroxine—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00234	0.0045	CcSEcCtD
Dextrothyroxine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.00446	CcSEcCtD
Dextrothyroxine—Alopecia—Dactinomycin—uterine cancer	0.00231	0.00443	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—YWHAE—uterine cancer	0.0023	0.0133	CbGpPWpGaD
Dextrothyroxine—Sweating increased—Etoposide—uterine cancer	0.0023	0.00442	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.0023	0.00442	CcSEcCtD
Dextrothyroxine—Fatigue—Progesterone—uterine cancer	0.00226	0.00435	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00217	0.00416	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Progesterone—uterine cancer	0.00216	0.00416	CcSEcCtD
Dextrothyroxine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00215	0.00413	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Progesterone—uterine cancer	0.00214	0.00412	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—ESR2—uterine cancer	0.00213	0.0123	CbGpPWpGaD
Dextrothyroxine—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00212	0.00407	CcSEcCtD
Dextrothyroxine—Urticaria—Progesterone—uterine cancer	0.00208	0.00401	CcSEcCtD
Dextrothyroxine—Acute coronary syndrome—Etoposide—uterine cancer	0.00207	0.00399	CcSEcCtD
Dextrothyroxine—Abdominal pain—Progesterone—uterine cancer	0.00207	0.00399	CcSEcCtD
Dextrothyroxine—Body temperature increased—Progesterone—uterine cancer	0.00207	0.00399	CcSEcCtD
Dextrothyroxine—Myocardial infarction—Etoposide—uterine cancer	0.00206	0.00397	CcSEcCtD
Dextrothyroxine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00205	0.00394	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—CDKN1B—uterine cancer	0.00198	0.0115	CbGpPWpGaD
Dextrothyroxine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00196	0.00377	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00194	0.00374	CcSEcCtD
Dextrothyroxine—Coma—Epirubicin—uterine cancer	0.00193	0.0037	CcSEcCtD
Dextrothyroxine—TPO—Differentiation Pathway—VEGFA—uterine cancer	0.00192	0.0111	CbGpPWpGaD
Dextrothyroxine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00189	0.00363	CcSEcCtD
Dextrothyroxine—Asthenia—Progesterone—uterine cancer	0.00188	0.00362	CcSEcCtD
Dextrothyroxine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00361	CcSEcCtD
Dextrothyroxine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00188	0.00361	CcSEcCtD
Dextrothyroxine—Pruritus—Progesterone—uterine cancer	0.00186	0.00357	CcSEcCtD
Dextrothyroxine—Diarrhoea—Progesterone—uterine cancer	0.00179	0.00345	CcSEcCtD
Dextrothyroxine—Coma—Doxorubicin—uterine cancer	0.00178	0.00343	CcSEcCtD
Dextrothyroxine—Flushing—Etoposide—uterine cancer	0.00175	0.00337	CcSEcCtD
Dextrothyroxine—SLC7A5—Aryl Hydrocarbon Receptor Pathway—EP300—uterine cancer	0.00174	0.0101	CbGpPWpGaD
Dextrothyroxine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00171	0.00328	CcSEcCtD
Dextrothyroxine—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00169	0.00325	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Epirubicin—uterine cancer	0.00169	0.00325	CcSEcCtD
Dextrothyroxine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00168	0.00323	CcSEcCtD
Dextrothyroxine—Alopecia—Etoposide—uterine cancer	0.00167	0.00321	CcSEcCtD
Dextrothyroxine—Vomiting—Progesterone—uterine cancer	0.00167	0.00321	CcSEcCtD
Dextrothyroxine—Rash—Progesterone—uterine cancer	0.00165	0.00318	CcSEcCtD
Dextrothyroxine—Dermatitis—Progesterone—uterine cancer	0.00165	0.00318	CcSEcCtD
Dextrothyroxine—Headache—Progesterone—uterine cancer	0.00164	0.00316	CcSEcCtD
Dextrothyroxine—Increased appetite—Epirubicin—uterine cancer	0.00163	0.00313	CcSEcCtD
Dextrothyroxine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00163	0.00313	CcSEcCtD
Dextrothyroxine—Fatigue—Dactinomycin—uterine cancer	0.0016	0.00307	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Epirubicin—uterine cancer	0.00157	0.00302	CcSEcCtD
Dextrothyroxine—Cardiac failure—Epirubicin—uterine cancer	0.00157	0.00302	CcSEcCtD
Dextrothyroxine—Cardiac failure congestive—Doxorubicin—uterine cancer	0.00156	0.003	CcSEcCtD
Dextrothyroxine—Nausea—Progesterone—uterine cancer	0.00156	0.003	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Dactinomycin—uterine cancer	0.00153	0.00294	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00152	0.00292	CcSEcCtD
Dextrothyroxine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00151	0.00291	CcSEcCtD
Dextrothyroxine—Increased appetite—Doxorubicin—uterine cancer	0.00151	0.0029	CcSEcCtD
Dextrothyroxine—Affect lability—Epirubicin—uterine cancer	0.00151	0.0029	CcSEcCtD
Dextrothyroxine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00288	CcSEcCtD
Dextrothyroxine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.0015	0.00288	CcSEcCtD
Dextrothyroxine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00149	0.00286	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—VEGFA—uterine cancer	0.00149	0.00862	CbGpPWpGaD
Dextrothyroxine—Abdominal pain—Dactinomycin—uterine cancer	0.00147	0.00282	CcSEcCtD
Dextrothyroxine—Body temperature increased—Dactinomycin—uterine cancer	0.00147	0.00282	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Epirubicin—uterine cancer	0.00145	0.0028	CcSEcCtD
Dextrothyroxine—Hypoglycaemia—Doxorubicin—uterine cancer	0.00145	0.00279	CcSEcCtD
Dextrothyroxine—Cardiac failure—Doxorubicin—uterine cancer	0.00145	0.00279	CcSEcCtD
Dextrothyroxine—Mood swings—Epirubicin—uterine cancer	0.00145	0.00279	CcSEcCtD
Dextrothyroxine—Convulsion—Etoposide—uterine cancer	0.00142	0.00274	CcSEcCtD
Dextrothyroxine—Dehydration—Epirubicin—uterine cancer	0.00142	0.00274	CcSEcCtD
Dextrothyroxine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00141	0.00271	CcSEcCtD
Dextrothyroxine—Affect lability—Doxorubicin—uterine cancer	0.00139	0.00268	CcSEcCtD
Dextrothyroxine—THRB—Gene Expression—PHF1—uterine cancer	0.00138	0.00802	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—PHF1—uterine cancer	0.00138	0.00802	CbGpPWpGaD
Dextrothyroxine—SLCO4C1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00138	0.00798	CbGpPWpGaD
Dextrothyroxine—SLCO4A1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00138	0.00798	CbGpPWpGaD
Dextrothyroxine—Confusional state—Etoposide—uterine cancer	0.00135	0.0026	CcSEcCtD
Dextrothyroxine—Muscular weakness—Epirubicin—uterine cancer	0.00135	0.0026	CcSEcCtD
Dextrothyroxine—Cardiac arrest—Doxorubicin—uterine cancer	0.00135	0.00259	CcSEcCtD
Dextrothyroxine—Mood swings—Doxorubicin—uterine cancer	0.00134	0.00258	CcSEcCtD
Dextrothyroxine—Asthenia—Dactinomycin—uterine cancer	0.00133	0.00256	CcSEcCtD
Dextrothyroxine—Dysphagia—Epirubicin—uterine cancer	0.00132	0.00254	CcSEcCtD
Dextrothyroxine—Dehydration—Doxorubicin—uterine cancer	0.00132	0.00253	CcSEcCtD
Dextrothyroxine—Tachycardia—Etoposide—uterine cancer	0.00131	0.00252	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Etoposide—uterine cancer	0.0013	0.00249	CcSEcCtD
Dextrothyroxine—Angina pectoris—Epirubicin—uterine cancer	0.00129	0.00248	CcSEcCtD
Dextrothyroxine—Diarrhoea—Dactinomycin—uterine cancer	0.00127	0.00244	CcSEcCtD
Dextrothyroxine—SLC7A5—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00126	0.0073	CbGpPWpGaD
Dextrothyroxine—Muscular weakness—Doxorubicin—uterine cancer	0.00125	0.0024	CcSEcCtD
Dextrothyroxine—Dysphagia—Doxorubicin—uterine cancer	0.00122	0.00235	CcSEcCtD
Dextrothyroxine—Weight decreased—Epirubicin—uterine cancer	0.0012	0.0023	CcSEcCtD
Dextrothyroxine—Dyspnoea—Etoposide—uterine cancer	0.0012	0.0023	CcSEcCtD
Dextrothyroxine—Angina pectoris—Doxorubicin—uterine cancer	0.00119	0.00229	CcSEcCtD
Dextrothyroxine—Vomiting—Dactinomycin—uterine cancer	0.00118	0.00227	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—CHD4—uterine cancer	0.00118	0.00682	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—CHD4—uterine cancer	0.00118	0.00682	CbGpPWpGaD
Dextrothyroxine—Rash—Dactinomycin—uterine cancer	0.00117	0.00225	CcSEcCtD
Dextrothyroxine—Fatigue—Etoposide—uterine cancer	0.00116	0.00222	CcSEcCtD
Dextrothyroxine—SLCO1C1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.00115	0.00669	CbGpPWpGaD
Dextrothyroxine—Sweating—Epirubicin—uterine cancer	0.00113	0.00217	CcSEcCtD
Dextrothyroxine—Weight decreased—Doxorubicin—uterine cancer	0.00111	0.00213	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Etoposide—uterine cancer	0.00111	0.00213	CcSEcCtD
Dextrothyroxine—Nausea—Dactinomycin—uterine cancer	0.0011	0.00212	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Etoposide—uterine cancer	0.0011	0.00211	CcSEcCtD
Dextrothyroxine—Urticaria—Etoposide—uterine cancer	0.00107	0.00205	CcSEcCtD
Dextrothyroxine—Abdominal pain—Etoposide—uterine cancer	0.00106	0.00204	CcSEcCtD
Dextrothyroxine—Body temperature increased—Etoposide—uterine cancer	0.00106	0.00204	CcSEcCtD
Dextrothyroxine—Sweating—Doxorubicin—uterine cancer	0.00105	0.00201	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—PGR—uterine cancer	0.00102	0.00591	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—PGR—uterine cancer	0.00102	0.00591	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—SUZ12—uterine cancer	0.000986	0.00572	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—SUZ12—uterine cancer	0.000986	0.00572	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—NDUFB11—uterine cancer	0.000986	0.00572	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—SRD5A2—uterine cancer	0.000986	0.00572	CbGpPWpGaD
Dextrothyroxine—Flushing—Epirubicin—uterine cancer	0.000982	0.00189	CcSEcCtD
Dextrothyroxine—Asthenia—Etoposide—uterine cancer	0.000963	0.00185	CcSEcCtD
Dextrothyroxine—Pruritus—Etoposide—uterine cancer	0.000949	0.00183	CcSEcCtD
Dextrothyroxine—THRA—Endochondral Ossification—AKT1—uterine cancer	0.000948	0.0055	CbGpPWpGaD
Dextrothyroxine—Arrhythmia—Epirubicin—uterine cancer	0.000946	0.00182	CcSEcCtD
Dextrothyroxine—Alopecia—Epirubicin—uterine cancer	0.000935	0.0018	CcSEcCtD
Dextrothyroxine—Diarrhoea—Etoposide—uterine cancer	0.000918	0.00177	CcSEcCtD
Dextrothyroxine—Flushing—Doxorubicin—uterine cancer	0.000909	0.00175	CcSEcCtD
Dextrothyroxine—Tension—Epirubicin—uterine cancer	0.000904	0.00174	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—ESR2—uterine cancer	0.000898	0.00521	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—ESR2—uterine cancer	0.000898	0.00521	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CXCL8—uterine cancer	0.000897	0.0052	CbGpPWpGaD
Dextrothyroxine—Nervousness—Epirubicin—uterine cancer	0.000895	0.00172	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—NRAS—uterine cancer	0.000881	0.0051	CbGpPWpGaD
Dextrothyroxine—Arrhythmia—Doxorubicin—uterine cancer	0.000875	0.00168	CcSEcCtD
Dextrothyroxine—Alopecia—Doxorubicin—uterine cancer	0.000865	0.00166	CcSEcCtD
Dextrothyroxine—Vomiting—Etoposide—uterine cancer	0.000853	0.00164	CcSEcCtD
Dextrothyroxine—Agitation—Epirubicin—uterine cancer	0.000847	0.00163	CcSEcCtD
Dextrothyroxine—Rash—Etoposide—uterine cancer	0.000846	0.00163	CcSEcCtD
Dextrothyroxine—Dermatitis—Etoposide—uterine cancer	0.000845	0.00163	CcSEcCtD
Dextrothyroxine—Headache—Etoposide—uterine cancer	0.00084	0.00162	CcSEcCtD
Dextrothyroxine—Tension—Doxorubicin—uterine cancer	0.000837	0.00161	CcSEcCtD
Dextrothyroxine—Nervousness—Doxorubicin—uterine cancer	0.000828	0.00159	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—CTNNB1—uterine cancer	0.000828	0.0048	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—IRF1—uterine cancer	0.000817	0.00474	CbGpPWpGaD
Dextrothyroxine—Palpitations—Epirubicin—uterine cancer	0.000814	0.00157	CcSEcCtD
Dextrothyroxine—Convulsion—Epirubicin—uterine cancer	0.000798	0.00154	CcSEcCtD
Dextrothyroxine—Nausea—Etoposide—uterine cancer	0.000797	0.00153	CcSEcCtD
Dextrothyroxine—Arthralgia—Epirubicin—uterine cancer	0.000784	0.00151	CcSEcCtD
Dextrothyroxine—Agitation—Doxorubicin—uterine cancer	0.000784	0.00151	CcSEcCtD
Dextrothyroxine—Anxiety—Epirubicin—uterine cancer	0.000782	0.0015	CcSEcCtD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—EP300—uterine cancer	0.000769	0.00446	CbGpPWpGaD
Dextrothyroxine—Confusional state—Epirubicin—uterine cancer	0.000758	0.00146	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—KRAS—uterine cancer	0.000758	0.00439	CbGpPWpGaD
Dextrothyroxine—Palpitations—Doxorubicin—uterine cancer	0.000753	0.00145	CcSEcCtD
Dextrothyroxine—Shock—Epirubicin—uterine cancer	0.00074	0.00142	CcSEcCtD
Dextrothyroxine—Convulsion—Doxorubicin—uterine cancer	0.000739	0.00142	CcSEcCtD
Dextrothyroxine—Tachycardia—Epirubicin—uterine cancer	0.000734	0.00141	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000731	0.00424	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—CDKN2B—uterine cancer	0.000731	0.00424	CbGpPWpGaD
Dextrothyroxine—THRB—SIDS Susceptibility Pathways—VEGFA—uterine cancer	0.000729	0.00422	CbGpPWpGaD
Dextrothyroxine—Hyperhidrosis—Epirubicin—uterine cancer	0.000727	0.0014	CcSEcCtD
Dextrothyroxine—Arthralgia—Doxorubicin—uterine cancer	0.000726	0.0014	CcSEcCtD
Dextrothyroxine—Anxiety—Doxorubicin—uterine cancer	0.000723	0.00139	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—AKR1B1—uterine cancer	0.000713	0.00413	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—STAR—uterine cancer	0.000713	0.00413	CbGpPWpGaD
Dextrothyroxine—Confusional state—Doxorubicin—uterine cancer	0.000702	0.00135	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—PIK3CA—uterine cancer	0.000696	0.00404	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000685	0.00132	CcSEcCtD
Dextrothyroxine—Shock—Doxorubicin—uterine cancer	0.000685	0.00132	CcSEcCtD
Dextrothyroxine—Insomnia—Epirubicin—uterine cancer	0.00068	0.00131	CcSEcCtD
Dextrothyroxine—Tachycardia—Doxorubicin—uterine cancer	0.000679	0.00131	CcSEcCtD
Dextrothyroxine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000673	0.00129	CcSEcCtD
Dextrothyroxine—Dyspnoea—Epirubicin—uterine cancer	0.00067	0.00129	CcSEcCtD
Dextrothyroxine—THRB—Generic Transcription Pathway—SMAD3—uterine cancer	0.000667	0.00387	CbGpPWpGaD
Dextrothyroxine—THRA—Generic Transcription Pathway—SMAD3—uterine cancer	0.000667	0.00387	CbGpPWpGaD
Dextrothyroxine—Fatigue—Epirubicin—uterine cancer	0.000648	0.00125	CcSEcCtD
Dextrothyroxine—SLC7A5—Cell surface interactions at the vascular wall—HRAS—uterine cancer	0.000644	0.00373	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	0.000638	0.0037	CbGpPWpGaD
Dextrothyroxine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000634	0.00122	CcSEcCtD
Dextrothyroxine—Insomnia—Doxorubicin—uterine cancer	0.000629	0.00121	CcSEcCtD
Dextrothyroxine—Dyspnoea—Doxorubicin—uterine cancer	0.00062	0.00119	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Epirubicin—uterine cancer	0.00062	0.00119	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000615	0.00118	CcSEcCtD
Dextrothyroxine—Fatigue—Doxorubicin—uterine cancer	0.0006	0.00115	CcSEcCtD
Dextrothyroxine—Urticaria—Epirubicin—uterine cancer	0.000597	0.00115	CcSEcCtD
Dextrothyroxine—Abdominal pain—Epirubicin—uterine cancer	0.000594	0.00114	CcSEcCtD
Dextrothyroxine—Body temperature increased—Epirubicin—uterine cancer	0.000594	0.00114	CcSEcCtD
Dextrothyroxine—Feeling abnormal—Doxorubicin—uterine cancer	0.000573	0.0011	CcSEcCtD
Dextrothyroxine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000569	0.00109	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—POLD1—uterine cancer	0.000559	0.00324	CbGpPWpGaD
Dextrothyroxine—Urticaria—Doxorubicin—uterine cancer	0.000553	0.00106	CcSEcCtD
Dextrothyroxine—Abdominal pain—Doxorubicin—uterine cancer	0.00055	0.00106	CcSEcCtD
Dextrothyroxine—Body temperature increased—Doxorubicin—uterine cancer	0.00055	0.00106	CcSEcCtD
Dextrothyroxine—THRA—Generic Transcription Pathway—ESR1—uterine cancer	0.000545	0.00316	CbGpPWpGaD
Dextrothyroxine—THRB—Generic Transcription Pathway—ESR1—uterine cancer	0.000545	0.00316	CbGpPWpGaD
Dextrothyroxine—Asthenia—Epirubicin—uterine cancer	0.00054	0.00104	CcSEcCtD
Dextrothyroxine—Pruritus—Epirubicin—uterine cancer	0.000532	0.00102	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—AKR1C1—uterine cancer	0.000523	0.00303	CbGpPWpGaD
Dextrothyroxine—Diarrhoea—Epirubicin—uterine cancer	0.000515	0.00099	CcSEcCtD
Dextrothyroxine—Asthenia—Doxorubicin—uterine cancer	0.000499	0.00096	CcSEcCtD
Dextrothyroxine—Pruritus—Doxorubicin—uterine cancer	0.000492	0.000947	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—PGR—uterine cancer	0.000491	0.00285	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—PGR—uterine cancer	0.000491	0.00285	CbGpPWpGaD
Dextrothyroxine—Vomiting—Epirubicin—uterine cancer	0.000478	0.00092	CcSEcCtD
Dextrothyroxine—Diarrhoea—Doxorubicin—uterine cancer	0.000476	0.000916	CcSEcCtD
Dextrothyroxine—Rash—Epirubicin—uterine cancer	0.000474	0.000912	CcSEcCtD
Dextrothyroxine—Dermatitis—Epirubicin—uterine cancer	0.000474	0.000911	CcSEcCtD
Dextrothyroxine—Headache—Epirubicin—uterine cancer	0.000471	0.000906	CcSEcCtD
Dextrothyroxine—THRA—Gene Expression—EZH2—uterine cancer	0.000466	0.0027	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—EZH2—uterine cancer	0.000466	0.0027	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—RRM2—uterine cancer	0.000466	0.0027	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—STAR—uterine cancer	0.000462	0.00268	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	0.000462	0.00268	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—DCN—uterine cancer	0.000453	0.00262	CbGpPWpGaD
Dextrothyroxine—Nausea—Epirubicin—uterine cancer	0.000447	0.000859	CcSEcCtD
Dextrothyroxine—Vomiting—Doxorubicin—uterine cancer	0.000442	0.000851	CcSEcCtD
Dextrothyroxine—SLCO1B1—Transmembrane transport of small molecules—ABCC9—uterine cancer	0.000439	0.00254	CbGpPWpGaD
Dextrothyroxine—Rash—Doxorubicin—uterine cancer	0.000439	0.000844	CcSEcCtD
Dextrothyroxine—Dermatitis—Doxorubicin—uterine cancer	0.000438	0.000843	CcSEcCtD
Dextrothyroxine—Headache—Doxorubicin—uterine cancer	0.000436	0.000838	CcSEcCtD
Dextrothyroxine—THRB—Gene Expression—ESR2—uterine cancer	0.000432	0.00251	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—ESR2—uterine cancer	0.000432	0.00251	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—CYP11A1—uterine cancer	0.000427	0.00247	CbGpPWpGaD
Dextrothyroxine—Nausea—Doxorubicin—uterine cancer	0.000413	0.000795	CcSEcCtD
Dextrothyroxine—TPO—Metabolism—AKR1C3—uterine cancer	0.000403	0.00233	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—CDKN2B—uterine cancer	0.000352	0.00204	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—CDKN2B—uterine cancer	0.000352	0.00204	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	0.000339	0.00196	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—SMAD3—uterine cancer	0.000321	0.00186	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—SMAD3—uterine cancer	0.000321	0.00186	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—CYP19A1—uterine cancer	0.000314	0.00182	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—STK11—uterine cancer	0.000314	0.00182	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—SRD5A2—uterine cancer	0.000284	0.00165	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—NDUFB11—uterine cancer	0.000284	0.00165	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	0.000276	0.0016	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—ESR1—uterine cancer	0.000262	0.00152	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—ESR1—uterine cancer	0.000262	0.00152	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	0.000261	0.00151	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—EP300—uterine cancer	0.000255	0.00148	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—VEGFA—uterine cancer	0.000242	0.0014	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—NRAS—uterine cancer	0.000239	0.00138	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—MTHFR—uterine cancer	0.000236	0.00137	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—AKR1B1—uterine cancer	0.000206	0.00119	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—STAR—uterine cancer	0.000206	0.00119	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—KRAS—uterine cancer	0.000206	0.00119	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	0.000203	0.00118	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—PIK3CA—uterine cancer	0.000189	0.00109	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—TP53—uterine cancer	0.000183	0.00106	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—HRAS—uterine cancer	0.000175	0.00101	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—POLD1—uterine cancer	0.000161	0.000935	CbGpPWpGaD
Dextrothyroxine—SLC7A5—Hemostasis—AKT1—uterine cancer	0.000154	0.000894	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—AKR1C1—uterine cancer	0.000151	0.000875	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—RRM2—uterine cancer	0.000134	0.00078	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PTEN—uterine cancer	0.000131	0.00076	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—DCN—uterine cancer	0.000131	0.000757	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—EP300—uterine cancer	0.000125	0.000725	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—CYP11A1—uterine cancer	0.000123	0.000713	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—AKR1C3—uterine cancer	0.000116	0.000673	CbGpPWpGaD
Dextrothyroxine—THRA—Gene Expression—AKT1—uterine cancer	9.46e-05	0.000548	CbGpPWpGaD
Dextrothyroxine—THRB—Gene Expression—AKT1—uterine cancer	9.46e-05	0.000548	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—PIK3CA—uterine cancer	9.25e-05	0.000536	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—CYP19A1—uterine cancer	9.05e-05	0.000525	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—STK11—uterine cancer	9.05e-05	0.000525	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	8.49e-05	0.000492	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	8.1e-05	0.00047	CbGpPWpGaD
Dextrothyroxine—TPO—Metabolism—AKT1—uterine cancer	7.56e-05	0.000438	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—MTHFR—uterine cancer	6.8e-05	0.000394	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.99e-05	0.000347	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PTEN—uterine cancer	3.78e-05	0.000219	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—EP300—uterine cancer	3.61e-05	0.000209	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—PIK3CA—uterine cancer	2.67e-05	0.000155	CbGpPWpGaD
Dextrothyroxine—SLCO1B1—Metabolism—AKT1—uterine cancer	2.18e-05	0.000126	CbGpPWpGaD
